Modulating glioblastoma chemotherapy response: Evaluating long non-coding RNA effects on DNA damage response, glioma stem cell function, and hypoxic processes

Glioblastoma (GBM) is the most common and aggressive primary adult brain tumor, with an estimated annual incidence of 17 000 new cases in the United States. Current treatments for GBM include chemotherapy, surgical resection, radiation therapy, and antiangiogenic therapy. However, despite the variou...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Edith, Liu, Kristie, Lee, Justin, Tsung, Kathleen, Chow, Frances, Attenello, Frank J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9466271/
https://www.ncbi.nlm.nih.gov/pubmed/36105389
http://dx.doi.org/10.1093/noajnl/vdac119

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9466271/
https://www.ncbi.nlm.nih.gov/pubmed/36105389
http://dx.doi.org/10.1093/noajnl/vdac119

Ejemplares similares